Top Markets
Coin of the day
Evofem Biosciences, Inc. Evofem Biosciences, Inc.

Evofem Biosciences, Inc.

EVFM
Rang in Aktien #38408
Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated... Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. The company's main office is situated in San Diego, California.
Aktienkurs
$0.007524
Marktkapitalisierung
$997.16K
Veränderung (1 Tag)
-5.95%
Veränderung (1 Jahr)
-22.43%
Land
US
Handel Evofem Biosciences, Inc. (EVFM)

Kategorie

Kursverlauf für Evofem Biosciences, Inc. (EVFM)
Höchster Schlusskurs: $0.01 am 2026-08-01

Niedrigster Schlusskurs: $125.17K am 2014-11-01
Kursverlauf der Aktie von Evofem Biosciences, Inc. von 2014 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -6.91%
2025 7.85%
2024 -86.14%
2023 -99.23%
2022 -98.83%
2021 -81.81%
2020 -64.76%
2019 68.56%
2018 -60.71%
2017 48.90%
2016 -76.12%
2015 -40.99%
2014 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$505.24 29.45%
US
$846.09 29.68%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE